LLY

1,078.2

+1.07%↑

JNJ

230.54

-1.72%↓

ABBV

213

-1.44%↓

UNH

377.51

-2.75%↓

AZN

187.71

+0.25%↑

LLY

1,078.2

+1.07%↑

JNJ

230.54

-1.72%↓

ABBV

213

-1.44%↓

UNH

377.51

-2.75%↓

AZN

187.71

+0.25%↑

LLY

1,078.2

+1.07%↑

JNJ

230.54

-1.72%↓

ABBV

213

-1.44%↓

UNH

377.51

-2.75%↓

AZN

187.71

+0.25%↑

LLY

1,078.2

+1.07%↑

JNJ

230.54

-1.72%↓

ABBV

213

-1.44%↓

UNH

377.51

-2.75%↓

AZN

187.71

+0.25%↑

LLY

1,078.2

+1.07%↑

JNJ

230.54

-1.72%↓

ABBV

213

-1.44%↓

UNH

377.51

-2.75%↓

AZN

187.71

+0.25%↑

Home・Aktien・Vivani Medical

Vivani Medical

Open

1.21 4.31

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.17

Max

1.22

Schlüsselkennzahlen
By Trading Economics
Einkommen	-147K -6.8M
Angestellte	42

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+212.5% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.9M 77M
Vorheriger Eröffnungskurs	-3.1
Vorheriger Schlusskurs	1.21

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Mai 2026, 08:24 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Uber's $11.6 Billion Takeover Approach Lifts Delivery Hero Shares

25. Mai 2026, 21:22 UTC

Ergebnisse

Disney's 'Mandalorian and Grogu' Conquers Memorial Day Weekend Box Office -- Barrons.com

25. Mai 2026, 20:50 UTC

Market Talk

Ergebnisse

Basic Materials Roundup: Market Talk

25. Mai 2026, 16:20 UTC

Market Talk

Ergebnisse

Basic Materials Roundup: Market Talk

25. Mai 2026, 16:01 UTC

Market Talk

China's Crude Imports Pullback Helps Cap Price Upside -- Market Talk

25. Mai 2026, 14:43 UTC

Market Talk

Oil Unlikely to Fall Significantly Until Hormuz Fully Reopens -- Market Talk

25. Mai 2026, 14:15 UTC

Market Talk

Crude Futures Retreat As U.S.-Iran Progress Toward Deal -- Market Talk

25. Mai 2026, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

25. Mai 2026, 12:58 UTC

Market Talk

Over 60% of Albertans Indicate No Interest in Separation From Canada -- Market Talk

25. Mai 2026, 12:56 UTC

Market Talk

Ergebnisse

Canadian Earnings Lifted by Higher Commodity Prices in Latest Quarter -- Market Talk

25. Mai 2026, 12:48 UTC

Market Talk

Interest-Rate Cuts Unlikely in 2026 Even if Middle East Conflict Ends -- Market Talk

25. Mai 2026, 12:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. Mai 2026, 12:34 UTC

Market Talk

Dollar Extends Falls on U.S.-Iran Deal Prospects -- Market Talk

25. Mai 2026, 12:10 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Delivery Hero's Assets Look Strategic -- Market Talk

25. Mai 2026, 11:00 UTC

Market Talk

Euro, Sterling, Riskier Currencies Rise Versus Weaker Dollar -- Market Talk

25. Mai 2026, 10:19 UTC

Market Talk

Swiss Franc Rises to Highest in More Than Two Months Vs Euro -- Market Talk

25. Mai 2026, 10:05 UTC

Ergebnisse

Tenaga Nasional: Well-Positioned to Navigate Global Geopolitical Uncertainties

25. Mai 2026, 10:04 UTC

Ergebnisse

Tenaga Nasional: Operational Performance to Remain Resilient in 2026

25. Mai 2026, 10:03 UTC

Ergebnisse

Tenaga Nasional: 1Q Operating Profit Rose on Higher Electricity Demand, Lower Fuel Prices

25. Mai 2026, 10:02 UTC

Ergebnisse

Tenaga Nasional: 1Q Rev Rose on Higher Electricity Sales

25. Mai 2026, 10:01 UTC

Ergebnisse

Tenaga Nasional 1Q Net Up 3.7% on Year

25. Mai 2026, 10:00 UTC

Ergebnisse

Tenaga Nasional 1Q Rev Up 6.6% on Year

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional Malaysia 1st-Quarter 2026 Earnings Summary Table

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q EPS MYR0.1883

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q Rev MYR17.1B

25. Mai 2026, 09:56 UTC

Ergebnisse

Tenaga Nasional 1Q Net MYR1.1B

25. Mai 2026, 09:38 UTC

Market Talk

U.S.-Iran Talks Lifted Sentiment But No Agreement Would Quickly Restore Normal Market Conditions -- Market Talk

25. Mai 2026, 09:33 UTC

Market Talk

Global Equities Roundup: Market Talk

25. Mai 2026, 09:33 UTC

Market Talk

India's Gold Import Tax Raise Won't Curb Demand -- Market Talk

25. Mai 2026, 08:55 UTC

Market Talk

European Energy Stocks Slide on Falling Oil Prices -- Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

212.5% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD 212.5%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.